&bgr;-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D &bgr;-lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
申请公布号
EP2831069(A4)
申请公布日期
2015.06.03
申请号
EP20130769389
申请日期
2013.03.29
申请人
CUBIST PHARMACEUTICALS, INC.
发明人
GU, YU GUI;HE, YONG;YIN, NING;ALEXANDER, DYLAN, C.;CROSS, JASON, B.;METCALF, CHESTER, A., III.;BUSCH, ROBERT
